Aspirins benefit in primary CVD prevention countered by bleeding risks

Aspirin’s benefit in primary CVD prevention countered by bleeding risks

Aspirin offers modest protection against cardiovascular events in primary prevention, but that benefit is at least partially offset by an increase in major bleeding events, according to a meta-analysis published Jan. 22 in JAMA.

More From BioPortfolio on "Aspirin’s benefit in primary CVD prevention countered by bleeding risks"